U.S. Blames Drug Shortages on Low Prices and a ‘Broken Marketplace’

A government task force suggested that providers pay more for lifesaving generics and that drug makers receive quality ratings.


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>